German American Bancorp, Inc. Gilead Sciences, Inc. Transaction History

German American Bancorp, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $2.52 Million - $2.75 Million	-39,669 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $460,560 - $525,498	7,676 Added 23.99%	39,669 $2.56 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $203,656 - $232,057	-3,595 Reduced 10.1%	31,993 $1.86 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $32,292 - $40,601	520 Added 1.48%	35,588 $2.25 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $2.18 Million - $2.53 Million	-30,173 Reduced 46.25%	35,068 $2.7 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $1.46 Million - $1.87 Million	23,361 Added 55.78%	65,241 $4.88 Million
Q4 2019 Feb 18, 2020	SELL	$61.62 - $67.78 $1.28 Million - $1.41 Million	-20,814 Reduced 33.2%	41,880 $2.72 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $159,150 - $175,674	-2,546 Reduced 3.9%	62,694 $3.97 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $196,746 - $220,628	3,180 Added 5.12%	65,240 $4.41 Million
Q1 2019 May 02, 2019	BUY	$62.53 - $70.05 $123,434 - $138,278	1,974 Added 3.29%	62,060 $4.03 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $113,451 - $148,046	1,874 Added 3.22%	60,086 $3.76 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $17,891 - $19,808	251 Added 0.43%	58,212 $4.5 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $3.76 Million - $4.39 Million	57,961 New	57,961 $4.11 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of German American Bancorp, Inc., based on Form 13F filings with the SEC.

Stay updated on German American Bancorp, Inc. with notifications on news.